A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

The National Institute for Cancer Research and Treatment (NICRAT) in partnership with a Roche, multinational healthcare ...

Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.

Current law mandates patients with metastatic breast cancer must wait five months before earning any SSDI benefits.

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free ...

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed on its ...

Roche programmeOver 32,000 new breast cancer cases are expected in Nigeria in the ongoing year,the Global Cancer Observatory,GCO, has said .The interactive web-based platform presenting global cancer ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

INVINCIBLE-3 Study, and 25 patients have been screened Eight Swiss sites are activated in the INVINCIBLE-4 Study, and several ...

A new law in Arkansas aims to remove the barriers associated with receiving breast cancer examinations. The bill was introduced by Representative Ryan Rose, a ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...